Darden University of Virginia (USA)
-
Progressive Insurance: Making Pay As You Drive a Snap for Consumers - Teaching Note
Farris, Paul W.; Steenburgh, Thomas J.; Maiden, Stephen E.Teaching Note DARDEN-M-0873TN-EMarketingTeaching note for product M-0873Starting at €0.00
-
China Supply Chain and COVID-19 - Teaching Note
Yang, Dennis; Sesia, AldoTeaching Note DARDEN-GEM-0184TN-EEconomicsTeaching Note for Product GEM-0184Starting at €0.00
-
China's Stock Market: Understanding Its Boom-and-Bust Cycles
Evans, Richard B.; Yang, Dennis; Qian, Junhui; Deng, YangmeiCase DARDEN-F-1985-EFinanceUsing the context of a private-bank chief economist preparing for a client call just as the Shanghai Stock Exchange Composite Index (SCI) reached a 29-month high on July 7, 2020, this case places students in a position to prepare an outlook on the prospects for investment in China. It also enables the comparison of China to various potential investment geographies, such as the United States and other financial markets around the globe. The mate...Starting at €8.20
-
Volatility in China's Stock Market: Boom, Bust, Boom…and Bust?
Evans, Richard B.; Qian, Junhui; Yang, DennisCase DARDEN-F-1759-EFinanceWith the Shanghai Stock Exchange Composite Index (SCI) dropping 5% at its opening, a circuit breaker was triggered and halted trading for 15 minutes. But when trading resumed, the market continued to drop, and a second circuit breaker was triggered, halting trading for the day. The overall SCI decline of 7.2% for the day was not just disastrous for Chinese investors, but it also caused a global panic that perhaps a global recession would ensure. ...Starting at €8.20
-
Pricing the EpiPen: This is Going to Sting
Steenburgh, Thomas J.Case DARDEN-M-0915-EMarketingThis case examines the public controversy that erupted over the increasingly high price of EpiPens. Mylan Inc. (Mylan), a generic drug maker, bought the EpiPen product line from Merck in 2007. Since that time, the company both invested in marketing to raise awareness for the drug and dramatically increased the price, lifting it from $100 to $600 per two pack in the U.S. In 2016, simmering consumer anger about the high prices of pharmaceutical dru...Starting at €8.20
-
GlobalGiving
Anik, Lalin; Steenburgh, Thomas J.; Steenburgh, LauraCase DARDEN-M-0938-EMarketingNonprofits are facing a growing challenge to retain donors. At a time when acquiring a new donor is three times as expensive as retaining an existing donor and donor attrition stands at an all-time high, nonprofits are looking to increase the lifetime value of their donors. This case presents a new means by which nonprofits can induce donors to give today and commit to giving in the future. The positive results of a low-cost, high-yield experimen...Starting at €8.20
-
Pricing the EpiPen: This is Going to Sting - Teaching Note
Steenburgh, Thomas J.Teaching Note DARDEN-M-0915TN-EMarketingTeaching note for product M-0915Starting at €0.00
-
The US - China Trade War: Deal or No Deal? - Teaching Note
Yang, Dennis; Holtz, PaulTeaching Note DARDEN-GEM-0175TN-ETeaching Note of Product GEM-0175Starting at €0.00
-
China Supply Chain and COVID-19
Yang, Dennis; Ha, Jiming; Yemen, Gerry; Sesia, AldoCase DARDEN-GEM-0184-EEconomicsOn March 11, 2020, The World Health Organization declared the outbreak of the novel coronavirus (COVID-19) a global pandemic. The pandemic brought production, trade, and businesses to a grinding halt, as governments closed borders and implemented lockdowns and restrictions; it also caused scrutiny of global supply chain strategies. While some US companies had already begun shifting outsourcing away from China during the US-China trade war amid th...Starting at €8.20
-
The US–China Trade War: Deal or No Deal?
Yang, Dennis; Ha, Jiming; Holtz, Paul; Yemen, GerryTechnical Note DARDEN-GEM-0175-EEconomicsThe US–China trade war in 2019 led to major shifts in global trade and supply chains, highlighting the recent trend in deglobalization. This case discusses the patterns of international trade and capital flows across the two countries, determinants of trade imbalances, and the role of national savings, policies, institutions, and exchange rates. The material allows for an examination of several factors, including the broader context of tech compe...Starting at €8.20